Chandra Bhagat Pharma (BOM:542934) Total Equity: ₹331 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542934 Chandra Bhagat Pharma Ltd BOM:542934
65 GF Score
Price ₹33.00
GF Value ₹70.18
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Chandra Bhagat Pharma Total Equity?

Chandra Bhagat Pharma BOM:542934 65 Total Equity is ₹331 Mil as of Mar. 2026. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.18 (Possible Value Trap). The stock has 4 warning signs investors should review.

Chandra Bhagat Pharma's total equity for the quarter that ended in Mar. 2026 was ₹331 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Chandra Bhagat Pharma Total Equity Historical Data

* Premium members only.

The historical data trend for Chandra Bhagat Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandra Bhagat Pharma Total Equity Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 266.76 274.79 290.09 299.69 331.27

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 290.09 296.94 299.69 304.18 331.27
BOM:542934
65GF Score
Chandra Bhagat Pharma Ltd BOM:542934
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandra Bhagat Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Chandra Bhagat Pharma's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=942.058-610.793
=331

Chandra Bhagat Pharma's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=942.058-610.793
=331

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹331 Mil mean?
Chandra Bhagat Pharma (BOM:542934) has a Total Equity of ₹331 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Chandra Bhagat Pharma and its competitors.
Is Chandra Bhagat Pharma's Total Equity too high?
Chandra Bhagat Pharma's current Total Equity is ₹331 Mil. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's Total Equity compare to MCK and CAH?
Chandra Bhagat Pharma's Total Equity of ₹331 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Distribution company?
A good Total Equity depends on the Medical Distribution industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Chandra Bhagat Pharma and its competitors. Chandra Bhagat Pharma's current Total Equity is ₹331 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.18, compared to a current price of ₹33.00 — trading 53% below its estimated fair value. The current Total Equity is ₹331 Mil. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current Total Equity is ₹331 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?

Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued. The current stock price of ₹33.00 is trading 53% below its estimated GF Value™ of ₹70.18. GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.

Key valuation signals for BOM:542934:

  • Total Equity: ₹331 Mil
  • GF Value™: ₹70.18 vs. price of ₹33.00 (53% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chandra Bhagat Pharma Business Description

Address Doctor Ambedkar Road, 323-F, Flat 1,2, Bhagat Bhuvan, Matunga East, Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score

Get the complete analysis for BOM:542934

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.00
Price
₹70.18
GF Value